Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice

Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E476-82. doi: 10.1152/ajpendo.00422.2005. Epub 2006 Apr 25.

Abstract

We have previously demonstrated that the insulin resistance associated with inducible nitric oxide synthase (iNOS) induction in two different models of obesity, diet-induced obesity and the ob/ob mice, is mediated by S-nitrosation of proteins involved in insulin signal transduction: insulin receptor beta-subunit (IRbeta), insulin receptor substrate 1(IRS-1), and Akt. S-nitrosation of IRbeta and Akt impairs their kinase activities, and S-nitrosation of IRS-1 reduces its tissue expression. In this study, we observed that LPS-induced insulin resistance in the muscle of wild-type mice, as demonstrated by reduced insulin-induced tyrosine phosphorylation of IRbeta and IRS-1, reduced IRS-1 expression and reduced insulin-induced serine phosphorylation of Akt. This resistance occurred in parallel with enhanced iNOS expression, which was accompanied by S-nitrosation of IRbeta/IRS-1 and Akt. In the muscle of iNOS(-/-) mice, we did not observe enhanced iNOS expression or any S-nitrosation of IRbeta/IRS-1 and Akt after LPS treatment. Moreover, insulin resistance was not present. The preservation of insulin-induced tyrosine phosphorylation of IRbeta and IRS-1, of IRS-1 protein expression, and of insulin-induced serine phosphorylation of Akt observed in LPS-treated iNOS(-/-) mice strongly suggests that the insulin resistance induced by LPS is iNOS mediated, probably through S-nitrosation of proteins of early steps of insulin signaling.

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Animals
  • Blood Glucose / metabolism
  • Insulin / pharmacology
  • Insulin Receptor Substrate Proteins
  • Insulin Resistance / physiology*
  • Lipopolysaccharides / pharmacology*
  • Liver / drug effects
  • Liver / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Nitric Oxide Synthase Type II / deficiency*
  • Nitric Oxide Synthase Type II / genetics
  • Nitrosation / drug effects
  • Phosphoproteins / metabolism*
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Receptor, Insulin / metabolism*

Substances

  • Blood Glucose
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Lipopolysaccharides
  • Phosphoproteins
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Receptor, Insulin
  • Proto-Oncogene Proteins c-akt